Declining Cancer Mortality
Cancer mortality in the U.S. has continued to decline from 2019 to 2023, primarily due to a reduction in lung cancer deaths. However, the incidence of cancer is still on the rise, according to data from the CDC.
Innovative Treatment Delivery
A 3D-printed, dissolving microneedle array loaded with medication has successfully passed initial tests as a potential transdermal delivery system for chemotherapy.
Clinical Trials Participation
Research suggests that bringing clinical trials to cancer patients, as opposed to requiring them to travel to trial sites, may enhance participation rates in studies aimed at improving therapeutic outcomes.
Diabetes and Cancer Risk
A recent study indicates that individuals with type 2 diabetes have double the risk of developing cancer compared to those without diabetes, findings that will be discussed at the upcoming European Association for the Study of Diabetes meeting.
Myeloma Survival Rates
Recent analysis shows that up to 87% of patients with relapsed/refractory multiple myeloma treated with teclistamab and daratumumab can expect survival rates comparable to those without myeloma.
New Cancer Treatments Approved
The FDA has approved belzutifan in combination with lenvatinib for previously treated advanced renal cell carcinoma with a clear cell component.
Clinical Trial Regulations
Compass Therapeutics reported that the FDA is seeking a survival-focused clinical trial for its drug tovecimig in biliary cancer, which the company believes is unnecessary prior to application submission.
Drug Pricing Concerns
Proposed Medicare drug price negotiation policies may pose financial challenges for oncology practices by mandating upfront payments at commercial prices.
Endocrine Therapy Adaptations
Breast cancer specialists frequently alter their approach to endocrine therapy after evaluating results from the Breast Cancer Index, often opting to extend treatment.
Stroke and Cancer Coagulopathy
A systematic review has provided new insights into the relationship between stroke and cancer-associated coagulopathy.
Vitamin C and Cancer Prevention
Vitamin C supplements may be beneficial in preventing myeloid malignancies like myelogenous leukemias in patients with blood disorders that predispose them to cancer.
Impact of Budget Cuts on Trials
Recent budget cuts at the National Cancer Institute have delayed patient enrollment in a clinical trial for an aggressive childhood brain cancer, illustrating the challenges in cancer research funding.
Exercise Benefits for Survivors
Colorectal cancer survivors who engage in physical activity, particularly walking, report less fatigue according to a longitudinal study.
Disclaimer
The information provided in this article is for educational purposes only and should not be considered as medical advice. Please consult with a healthcare professional for personalized guidance and treatment options.
Fuente: https://www.medpagetoday.com/hematologyoncology/othercancers/123150
Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.
